| Select | Title | Policy Type | Year |
|---|---|---|---|
|
EspAddText
EspRemoveText
|
Regulation of Self-Care Products in Canada | Response to consultation | 2016 |
|
EspAddText
EspRemoveText
|
Statement to the House of Commons Committee on Health addressing the opioid crisis in Canada | Parliamentary submission | 2016 |
|
EspAddText
EspRemoveText
|
Health Canada’s Consultation on “Plain and Standardized Packaging” | Response to consultation | 2016 |
|
EspAddText
EspRemoveText
|
Regulatory framework for the mandatory reporting of adverse drug reactions and medical device incidents by provincial and territorial healthcare institutions. | Response to consultation | 2016 |